Q32 BIO INC
QTTBNASDAQ🏆 #3391 by market capEarnings Nov 5US Equity
$8.87▼ $0.19 (−2.10%)
🌙 After hours$8.87▲ 0.00%Regular close · extended-hours price shownTrack QTTB
Get earnings, price moves & breaking news on Telegram
24h▼ 2.1%
7d▲ 2.8%
14d▲ 18.3%
30d▲ 7.8%
ytd▲ 170.4%
1y▲ 222.5%
🏦Market Cap
$264M
Small Cap
📈Revenue Growth (YoY)
0.0%
Slowing
📊Gross Margin
99.8%
High
💵FCF Margin
-36.9%
Thin
⚖️P/S Ratio
4.9x
Fair
Otter Score
64
Fair
Q32 BIO INC
QTTBAnalyst Ratings
Price
$8.87
Total
8
Raised
1
Lowered
5
Avg PT
$36.50
H / L
$66 / $14
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-07-28 | — | — |
Wells Fargo | Upgraded | Equal Weight → Overweight | 2026-07-13 | $66.00 | +644.10% |
Oppenheimer | Reiterated | Outperform | 2026-07-13 | $40.00 | +351.00% |
BMO Capital | Downgraded | Outperform → Market Perform | 2025-02-11 | $64.00 | +621.50% |
Piper Sandler | Downgraded | Overweight → Neutral | 2025-02-11 | $45.00 | +407.30% |
Guggenheim | Downgraded | Buy → Neutral | 2024-12-12 | — | — |
Raymond James | Downgraded | Strong Buy → Outperform | 2024-12-11 | $45.00 | +407.30% |
Leerink Partners | Downgraded | Outperform → Market Perform | 2024-12-11 | $54.00 | +508.80% |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-07-28
—
—
Wells Fargo
Upgraded · Equal Weight → Overweight · 2026-07-13
$66.00
+644.10%
Oppenheimer
Reiterated · Outperform · 2026-07-13
$40.00
+351.00%
BMO Capital
Downgraded · Outperform → Market Perform · 2025-02-11
$64.00
+621.50%
Piper Sandler
Downgraded · Overweight → Neutral · 2025-02-11
$45.00
+407.30%
Guggenheim
Downgraded · Buy → Neutral · 2024-12-12
—
—
Raymond James
Downgraded · Strong Buy → Outperform · 2024-12-11
$45.00
+407.30%
Leerink Partners
Downgraded · Outperform → Market Perform · 2024-12-11
$54.00
+508.80%
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space